Gagner Michel, Hutchinson Colleen, Rosenthal Raul
Herbert Wertheim College of Medicine, Florida International University, Miami, Florida; Department of Surgery, Hopital du Sacre Coeur, Montreal, Quebec, Canada.
Cleveland Clinic Florida, Weston, Florida.
Surg Obes Relat Dis. 2016 May;12(4):750-756. doi: 10.1016/j.soard.2016.01.022. Epub 2016 Jan 25.
For the purpose of building best practice guidelines, an international expert panel was surveyed in 2014 and compared with the 2011 Sleeve Gastrectomy Consensus and with survey data culled from a general surgeon audience.
To measure advancement on aspects of laparoscopic sleeve gastrectomy and identify current best practices.
International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO) 2014, Fifth International Summit for Laparoscopic Sleeve Gastrectomy, Montréal, Canada.
In August 2014, expert surgeons (based on having performed>1000 cases) completed an online anonymous survey. Identical survey questions were then administered to general surgeon attendees.
One hundred twenty bariatric surgeons completed the expert survey, along with 103 bariatric surgeons from IFSO 2014 general surgeon audience. The following indications were endorsed: as a stand-alone procedure (97.5%); in high-risk patients (92.4%); in kidney and liver transplant candidates (91.6%); in patients with metabolic syndrome (83.8%); body mass index 30-35 with associated co-morbidities (79.8%); in patients with inflammatory bowel disease (87.4%); and in the elderly (89.1%). Significant differences existed between the expert and general surgeons groups in endorsing several contraindications: Barrett's esophagus (80.0% versus 31.3% [P<.001]), gastroesophageal reflux disease (23.3% versus 52.5% [P<.001]), hiatal hernias (11.7% versus 54.0% [P<.001]), and body mass index>60 kg/m(2) (5.0% versus 28.0% [P<.001]). Average reported weight loss outcomes 5 years postoperative were significantly higher for the expert surgeons group (P = .005), as were reported stricture (P = .001) and leakage (P = .005) rates. The following significant differences exist between 2014 and 2011 expert surgeons: Patients with gastroesophageal reflux disease should have pH and manometry study pre-laparoscopic sleeve gastrectomy (32.8% versus 50.0%; P = .033); it is important to take down the vessels before resection (88.1% versus 81.8%; P = .025); it is acceptable to buttress (81.4% versus 77.3%; P<.001); the smaller the bougie size and tighter the sleeve, the higher the incidence of leaks (78.8% versus 65.2%; P = .006).
This study highlights areas of new and improved best practices on various aspects of laparoscopic sleeve gastrectomy performance among experts from 2011 and 2014 and among the current general surgeon population.
为制定最佳实践指南,2014年对一个国际专家小组进行了调查,并与2011年袖状胃切除术共识以及从普通外科医生群体中收集的调查数据进行了比较。
评估腹腔镜袖状胃切除术各方面的进展,并确定当前的最佳实践。
2014年国际肥胖与代谢疾病外科学会(IFSO)第五届腹腔镜袖状胃切除术国际峰会,加拿大蒙特利尔。
2014年8月,专家外科医生(基于已完成超过1000例手术)完成了一项在线匿名调查。随后向参加IFSO 2014会议的普通外科医生与会者提出了相同的调查问题。
120名减肥外科医生完成了专家调查,IFSO 2014普通外科医生群体中有103名减肥外科医生参与。以下适应症得到认可:作为独立手术(97.5%);用于高危患者(92.4%);用于肾和肝移植候选者(91.6%);用于代谢综合征患者(83.8%);体重指数30 - 35且伴有相关合并症的患者(79.8%);用于炎症性肠病患者(87.4%);以及用于老年人(89.1%)。在认可几种禁忌症方面,专家组和普通外科医生组之间存在显著差异:巴雷特食管(80.0%对31.3% [P <.001])、胃食管反流病(23.3%对52.5% [P <.001])、食管裂孔疝(11.7%对54.0% [P <.001])以及体重指数>60 kg/m²(5.0%对28.0% [P <.001])。专家外科医生组术后5年报告的平均体重减轻结果显著更高(P =.005),报告的狭窄(P =.001)和渗漏(P =.005)率也是如此。2014年和2011年的专家外科医生之间存在以下显著差异:胃食管反流病患者在腹腔镜袖状胃切除术前行pH和测压研究(32.8%对50.0%;P =.033);切除前结扎血管很重要(88.1%对81.8%;P =.025);使用支撑物是可接受的(81.4%对77.3%;P <.001);探条尺寸越小且袖状胃越紧,渗漏发生率越高(78.8%对65.2%;P =.006)。
本研究突出了2011年和2014年专家以及当前普通外科医生群体在腹腔镜袖状胃切除术操作各方面新的和改进的最佳实践领域。